Abstract
Brucellae are facultative intracellular gram-negative bacteria that cause human disease and significant worldwide economic loss due to infection of livestock. Available vaccines against Brucella spp. are live attenuated Brucella strains. In order to engineer a better vaccine to be used in animals and humans, our laboratory aims to develop an innocuous subunit vaccine. Particularly, we are interested in Brucella membrane proteins (MPs). In this study, an immunoproteomic approach was utilized to identify novel antigenic candidate proteins from Chinese Brucella vaccine strain M5 membrane proteins. The membrane proteins were separated by 2-DE and analyzed by western-blotting for their reactivity with the antiserum obtained from goats naturally infected by Brucella. Of a total of 9 immunogenic proteins identified, 7 were shown to be the novel antigens for Brucella spp. Some of the major protein components include outer-membrane protein OMP25, OMP31, and several new immunogenic proteins were identified, such as isovaleryl coenzyme A dehydrogenase, nitroglycerin reductase, succinyl-CoA synthetase subunit and S- adenosine -L- homocysteine hydrolase. Comparing these gene sequences revealed that 8 out of 9 immunoreactive protein genes were found in all 5 different Brucella strains. The elucidation of the immunome of Brucella vaccine strain M5 MPs identified a number of candidate proteins for developing vaccines against Brucella infection in livestock.
Highlights
Brucellosis, one of the most important re-emerging zoonoses caused by bacteria of the genus Brucella, can affect many mammal species and is transmissible to humans, having an important socio-economic impact
The immunogenic proteins from B. melitensis vaccine strain M5 membrane proteins were identified by an immunoproteomics strategy
A sample preparation method combining carbonate extraction, novel zwitter ionic detergents and surfactant-free organic solvent-assisted solubilization was chosen for the isolating process of Brucella cell membrane
Summary
Brucellosis, one of the most important re-emerging zoonoses caused by bacteria of the genus Brucella, can affect many mammal species and is transmissible to humans, having an important socio-economic impact. It occurs in many countries and threatens almost 1/10-1/5 of the world’s population [1,2]. Brucella infections in livestock are usually prevented by administration of attenuated live vaccines These include Brucella abortus S19 strain, Brucella melitensis M5 strain and Brucella suis S2 strain which have been used for cattle, sheep and goats, and swine immunization in China, respectively [4,5]. Immunogenic Brucella membrane proteins are ideal vaccine candidates since they play important roles in bacterial toxicity, immune protection as well as intra and extra cellular signal transduction [12]
Sign-in/Register to view highlights & summary 
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call